| Next 10 |
Ad
TTOO News and Press T2 Biosystems Inc.
News | T2 Biosystems Inc. (NASDAQ:TTOO)
-
2025-04-06 18:49:24 ET T2 Biosystems, Inc. (TTOO) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 6.21%. The average open to low on the day of earnings was -11.03%. The average open to c...
-
2025-04-06 18:44:22 ET T2 Biosystems, Inc. (TTOO) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in TTOO stock price following earnings has averaged ±5.58% , with a median of 4.80%. ...
-
2025-01-07 10:40:13 ET More on T2 Biosystems T2 Biosystems GAAP EPS of -$0.57, revenue of $1.99M Financial information for T2 Biosystems Read the full article on Seeking Alpha For further details see: T2 Biosystems reports preliminary Q4 product revenues ...
-
LEXINGTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced preliminary unaudited financial and operational results for the f...
-
2024-12-18 09:20:36 ET More on T2 Biosystems T2 Biosystems, Inc. (TTOO) Q3 2024 Earnings Call Transcript T2 Biosystems, Inc. (TTOO) Business Update Conference Call Transcript T2 Biosystems reports 35% rise in Q3 revenue Financial information for T2 Biosystems...
-
LEXINGTON, Mass., Dec. 18, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the sale of four T2Dx ® Instruments to its European (EU) distributor that represents m...
-
LEXINGTON, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has surpassed the shipment of 250,000 sepsis tests, marking a significant milestone tha...
-
2024-12-16 09:06:14 ET More on T2 Biosystems T2 Biosystems GAAP EPS of -$0.57, revenue of $1.99M T2 Biosystems reports 35% rise in Q3 revenue Financial information for T2 Biosystems Read the full article on Seeking Alpha For further details see: T...
-
LEXINGTON, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to license its proprietary technology to expand its leadership i...
-
2024-11-14 18:12:55 ET T2 Biosystems, Inc. (TTOO) Q3 2024 Earnings Conference Call November 14, 2024 04:30 PM ET Company Participants Trip Taylor - Investor Relations John Sperzel - Chairman & Chief Executive Officer John Sprague - Chief Financial Officer ...
Stock Information
Get TTOO Alerts
News, Short Squeeze, Breakout and More Instantly...
T2 Biosystems Inc. Company Name:
TTOO Stock Symbol:
NASDAQ Market:
34.04% G/L:
$0.1453 Last:
316,936 Volume:
$0.1046 Open:
$0.1084 Close:
T2 Biosystems Inc. Website:
Ad
-
2025-04-06 18:49:24 ET T2 Biosystems, Inc. (TTOO) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 6.21%. The average open to low on the day of earnings was -11.03%. The average open to c...
-
2025-04-06 18:44:22 ET T2 Biosystems, Inc. (TTOO) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in TTOO stock price following earnings has averaged ±5.58% , with a median of 4.80%. ...
-
LEXINGTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced preliminary unaudited financial and operational results for the f...